Hypercalcaemia secondary to ectopic parathyroid hormone expression in an adolescent with metastatic alveolar rhabdomyosarcoma
Pediatric Blood & Cancer2017Vol. 65(1)
Citations Over Time
Abstract
We report the case of a 14-year-old male with metastatic alveolar rhabdomyosarcoma, presenting with hypercalcaemia (3.89 mmol/l) and elevated parathyroid hormone (PTH) level (10.2 pmol/l). Imaging demonstrated extensive bony lytic damage, with "floating teeth" in the mandible. Normalisation of calcium levels and bony reformation of the mandible occurred following chemotherapy; PTH levels decreased initially but remained above normal levels. Imaging did not demonstrate any evidence of parathyroid abnormality. Tumour ectopic PTH secretion is a very rare cause of hypercalcaemia of malignancy in children. Hypercalcaemia with an elevated PTH, in the absence of parathyroid-related cause, should prompt investigation for underlying malignancy.
Related Papers
- → Preclinical Testing of Erlotinib in a Transgenic Alveolar Rhabdomyosarcoma Mouse Model(2011)13 cited
- → Clinical Relevance of Molecular Diagnosis in Childhood Rhabdomyosarcoma(2000)37 cited
- → Refractory alveolar rhabdomyosarcoma in an 11-year-old male(2021)3 cited
- → Alveolar Sinonasal Rhabdomyosarcoma in Adults: A Case Report(2013)
- → Primary alveolar rhabdomyosarcoma of the breast skin: a case report and literature review(2022)